Inventaire - your friends and communities are your best library

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

Author

Ian P. Hall

Published in: The Lancet

Date of publication: October 1, 1997

Language: English

Main subject: asthma

Bibliographic databases:

Cites articles 18

Date

Title

Authors

January 1987

cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor

, ,
October 1, 1992

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma
April 1, 1993

Respiratory arrests in young asthmatics on salmeterol
April 1, 1993

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment
July 1, 1994

Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma
November 1, 1994

Risks of salmeterol?
May 1, 1994

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol
February 1, 1995

Implications of genetic variability of human beta 2-adrenergic receptor structure
July 1, 1995

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells
April 1, 1995

Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype
May 1, 1995

Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects

,
May 1, 1995

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients
July 1, 1995

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients
April 1, 1996

Beta 2 adrenoceptor polymorphisms: are they clinically important?
April 1, 1996

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol
November 1, 1996

Salmeterol tachyphylaxis in steroid treated asthmatic subjects
December 1, 1996

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist
July 1, 1997

Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients,Systemic Corticosteriod Rapidly Reverses Bronchodilator Subsensitivity Induced by Formoterol in Asthmatic Patients

Article -

Welcome to inventaire

The library of your friends and communities

You are offline